Clinical Trials Directory

Trials / Completed

CompletedNCT03813602

Detection of Cannabis Impairment With an Eye Tracker

Effects of Cannabis on Driver Performance and Eye Movements and Characteristics During Simulated Driving: Feasibility Study

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
19 Years – 26 Years
Healthy volunteers
Accepted

Summary

Cannabis is one of the widely used psychoactive substances in the world. With increasing legalization, the prevalence of driving under the influence of cannabis will undoubtedly rise. At present, roadside detection of cannabis intoxication is largely dependent on drug recognition experts who rely on changes in eye movements when impaired. In this regard, use of eye trackers can help to detect impairment in drivers. The purpose of the present study is to determine the feasibility of the use of eye trackers in detecting impairment in participants who smoked a cannabis cigarette.

Detailed description

Participants will attend one study session after determination of eligibility. During this session, they will smoke a cannabis cigarette with 12.5% THC prior to driving a simulator. Driving will be assessed prior to smoking cannabis and at 7 time points after smoking cannabis. Eye tracking measures will also be taken while driving after smoking cannabis. Blood will be drawn for determination of levels of the psychoactive substance THC and its metabolites. Saliva tests, urine tests and subjective tests will also be performed at various times points after smoking cannabis.

Conditions

Interventions

TypeNameDescription
DRUGCannabis Sativa750 mg cannabis cigarette with 12.5% THC

Timeline

Start date
2019-08-15
Primary completion
2019-11-15
Completion
2019-11-15
First posted
2019-01-23
Last updated
2019-12-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03813602. Inclusion in this directory is not an endorsement.